Using targeted therapy via genomic tumor testing for patients suffering from the most common type of lung cancer can help transform treatment for the disease, a new study conducted by researchers at Memorial Sloan Kettering reveals. The Lung Cancer Mutation Consortium (LCMC), composed of a group of 14 US hospitals, incorporated tumor genotyping into therapeutic decision-making for patients with lung adenocarcinomas. An oncogenic driver was detected in 64 percent ...
Read More
You have just read an article categorized health
titled Targeted Therapy for Advanced Lung Cancer Patients can Help Improve Care.
Written by:
editor -
Monday, May 26, 2014
There are currently no comments for "Targeted Therapy for Advanced Lung Cancer Patients can Help Improve Care"
Post a Comment